# Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

> **NCT00359801** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 1976 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Randomization to Exubera (insulin human [rDNA origin] inhalation powder) or Usual Diabetes Care
- **DRUG:** Randomization to Exubera (insulin human [rDNA origin] inhalation powder) or Usual Diabetes Care

## Key facts

- **NCT ID:** NCT00359801
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-12
- **Final completion:** 2009-04
- **Target enrollment:** 1976 (ACTUAL)
- **Last updated:** 2010-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359801, "Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00359801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*